VYYRF (Voyageur Pharmaceuticals) E10: $0.00 (As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
18 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals E10?

Voyageur Pharmaceuticals VYYRF +7.71% 18 E10 is $0.00 as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Voyageur Pharmaceuticals's adjusted earnings per share data for the three months ended in Feb. 2026 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Feb. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-29), Voyageur Pharmaceuticals's current stock price is $0.095. Voyageur Pharmaceuticals's E10 for the quarter that ended in Feb. 2026 was $0.00. Voyageur Pharmaceuticals's Shiller PE Ratio of today is .


Voyageur Pharmaceuticals  (OTCPK:VYYRF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Voyageur Pharmaceuticals E10 Related Terms


Voyageur Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals E10 Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.04 0.00 0.00 0.00

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 0.00 -0.02 0.00 0.00

VYYRF vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyageur Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's Shiller PE Ratio falls into.


VYYRF
18GF Score
Voyageur Pharmaceuticals Ltd VYYRF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Voyageur Pharmaceuticals's adjusted earnings per share data for the three months ended in Feb. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=0/131.0772*131.0772
=0.000

Current CPI (Feb. 2026) = 131.0772.

Voyageur Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201603 -0.001 101.054 -0.001
201606 -0.016 102.002 -0.021
201609 -0.002 101.765 -0.003
201612 -0.030 101.449 -0.039
201705 -0.007 103.108 -0.009
201708 -0.008 103.108 -0.010
201711 -0.008 103.740 -0.010
201802 -0.003 104.688 -0.004
201805 -0.003 105.399 -0.004
201808 0.001 106.031 0.001
201811 -0.005 105.478 -0.006
201902 -0.002 106.268 -0.002
201905 -0.001 107.927 -0.001
201908 -0.003 108.085 -0.004
201911 0.000 107.769 0.000
202002 -0.008 108.559 -0.010
202005 -0.003 107.532 -0.004
202008 -0.003 108.243 -0.004
202011 -0.005 108.796 -0.006
202102 -0.001 109.745 -0.001
202105 -0.003 111.404 -0.004
202108 -0.003 112.668 -0.003
202111 0.000 113.932 0.000
202202 -0.002 115.986 -0.002
202205 -0.004 120.016 -0.004
202208 -0.003 120.569 -0.003
202211 -0.007 121.675 -0.008
202302 -0.002 122.070 -0.002
202305 -0.003 124.045 -0.003
202308 -0.001 125.389 -0.001
202311 0.000 125.468 0.000
202402 0.000 125.468 0.000
202405 0.000 127.601 0.000
202408 0.000 127.838 0.000
202411 0.000 127.838 0.000
202502 -0.007 128.786 -0.007
202505 0.000 129.813 0.000
202508 -0.007 130.208 -0.007
202511 0.000 130.682 0.000
202602 0.000 131.077 0.000

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.00 mean?
Voyageur Pharmaceuticals (VYYRF) has a E10 of $0.00 as of Feb. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Voyageur Pharmaceuticals and its competitors.
Is Voyageur Pharmaceuticals' E10 too high?
Voyageur Pharmaceuticals' current E10 is $0.00. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' E10 compare to ZTS and UTHR?
Voyageur Pharmaceuticals' E10 of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Voyageur Pharmaceuticals and its competitors. Voyageur Pharmaceuticals's current E10 is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current E10 of $0.00. The current E10 is $0.00. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current E10 is $0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score

Get the complete analysis for VYYRF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price